ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Diethyl Ether → 3-tert-butoxycarbonyl-7-chloro-6-[5-(2,2-dimethyl-propyl)-pyridin-2-ylmethylthio]-2,3,4,5-tetrahydro-1H-benzo[d]azepine

HRID 911492
印刷

反応式

HRID 911492 の反応式
[CH2:1]([Mg]Cl)[C:2]([CH3:5])([CH3:4])[CH3:3].C(OCC)C.[C:13]([O:17][C:18]([N:20]1[CH2:26][CH2:25][C:24]2[C:27]([S:32][CH2:33][C:34]3[CH:39]=[CH:38][C:37](Br)=[CH:36][N:35]=3)=[C:28]([Cl:31])[CH:29]=[CH:30][C:23]=2[CH2:22][CH2:21]1)=[O:19])([CH3:16])([CH3:15])[CH3:14]>C1COCC1.CCOC(C)=O.[Cl-].[Zn+2].[Cl-].C1C=CC([PH+]([C]2[CH][CH][CH][CH]2)C2C=CC=CC=2)=CC=1.C1C=CC([PH+]([C]2[CH][CH][CH][CH]2)C2C=CC=CC=2)=CC=1.C(Cl)Cl.Cl[Pd]Cl.[Fe]>[C:13]([O:17][C:18]([N:20]1[CH2:26][CH2:25][C:24]2[C:27]([S:32][CH2:33][C:34]3[CH:39]=[CH:38][C:37]([CH2:1][C:2]([CH3:5])([CH3:4])[CH3:3])=[CH:36][N:35]=3)=[C:28]([Cl:31])[CH:29]=[CH:30][C:23]=2[CH2:22][CH2:21]1)=[O:19])([CH3:16])([CH3:14])[CH3:15]
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 3

HCID 3283Diethyl EtherHCID 576562493-tert-butoxycarbonyl-6-(5-bromopyridin-2-ylmethylthio)-7-chloro-2,3,4,5-tetrahydro-1H-benzo[d]azepineHCID 178418809HCID 178418809、化合物

生成物 1

HCID 667068963-tert-butoxycarbonyl-7-chloro-6-[5-(2,2-dimethyl-propyl)-pyridin-2-ylmethylthio]-2,3,4,5-tetrahydro-1H-benzo[d]azepine収率 24%

試薬・触媒・溶媒 4

HCID 3007855
Sinkkikloridi
触媒
HCID 53485975CID 53485975触媒
HCID 8028Tetrahydrofuran溶媒2 回
HCID 8857Ethyl Acetate溶媒

実験手順

To a stirred solution of 1.0 M neopentyl magnesium chloride in diethyl ether (50 mL, 50 mmol) at −78° C. under nitrogen, add via syringe a solution of 0.5 M zinc chloride in THF (100 mL, 50 mmol). Warm gradually to ambient temperature and transfer via syringe of this solution (25 mL, ˜8.33 mmol) to a stirred solution of 3-tert-butoxycarbonyl-6-(5-bromo-pyridin-2-ylmethylthio)-7-chloro-2,3,4,5-tetrahydro-1H-benzo[d]azepine (300 mg, 0.62 mmol) in THF (2 mL) at ambient temperature. Add dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) dichloromethane adduct (50 mg, 0.061 mmol) and heat at 65° C. for 6 h. Cool to ambient temperature, dilute with EtOAc, wash with water, dry over anhydrous MgSO4 and concentrate in vacuo. Purify by chromatography on silica gel eluting with hexane/EtOAc (6:1) to give 3-tert-butoxycarbonyl-7-chloro-6-[5-(2,2-dimethyl-propyl)-pyridin-2-ylmethylthio]-2,3,4,5-tetrahydro-1H-benzo[d]azepine as an oil (69 mg, 24%). MS (APCI+) m/z: 501 (M+H)+. Use a method similar to the General Procedure 1-4 to give the title compound as a white powder. MS (APCI+) m/z: 375 (M+H)+.

後処理

  1. customat ambient temperature
  2. temperatureCool to ambient temperature
  3. washwash with water
  4. dry with materialdry over anhydrous MgSO4
  5. concentrationconcentrate in vacuo
  6. customPurify by chromatography on silica gel eluting with hexane/EtOAc (6:1)

出典と根拠

ORDレコード
ord-0e9619f7688a4ef1b83775a6242eb3b2
出典データセット
uspto-grants-2011_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08022062B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート